company background image
MLZ logo

MediPharm Labs DB:MLZ Stock Report

Last Price

€0.046

Market Cap

€23.3m

7D

8.7%

1Y

0%

Updated

25 Mar, 2024

Data

Company Financials +

MLZ Stock Overview

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally.

MLZ fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

MediPharm Labs Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MediPharm Labs
Historical stock prices
Current Share PriceCA$0.046
52 Week HighCA$0.06
52 Week LowCA$0.03
Beta1.04
1 Month Change16.46%
3 Month Change15.29%
1 Year Change0%
3 Year Change-85.16%
5 Year Change-97.88%
Change since IPO-97.40%

Recent News & Updates

Recent updates

Shareholder Returns

MLZDE PharmaceuticalsDE Market
7D8.7%3.0%1.3%
1Y0%-25.6%6.4%

Return vs Industry: MLZ exceeded the German Pharmaceuticals industry which returned -25.6% over the past year.

Return vs Market: MLZ underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is MLZ's price volatile compared to industry and market?
MLZ volatility
MLZ Average Weekly Movement16.6%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: MLZ has not had significant price volatility in the past 3 months.

Volatility Over Time: MLZ's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2015130David Pidduckhttps://www.medipharmlabs.com

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products.

MediPharm Labs Corp. Fundamentals Summary

How do MediPharm Labs's earnings and revenue compare to its market cap?
MLZ fundamental statistics
Market cap€23.34m
Earnings (TTM)-€10.69m
Revenue (TTM)€20.08m

1.2x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MLZ income statement (TTM)
RevenueCA$29.55m
Cost of RevenueCA$25.96m
Gross ProfitCA$3.58m
Other ExpensesCA$19.31m
Earnings-CA$15.73m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 27, 2024

Earnings per share (EPS)-0.039
Gross Margin12.13%
Net Profit Margin-53.23%
Debt/Equity Ratio4.5%

How did MLZ perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.